@madamswer - Sanjay has done nothing with this business to give him any grounds of credibility.
He has demonstrated no ability to pass input costs on to customers, he failed at selling the contract manufacturing business before and the PGH share price is close enough to all time lows. Sure - input costs will(and are dropping) but his performance as CEO has been terrible for shareholders. I
am in at higher prices than current and maybe if you a e buying now then the returns are there but his performance should not be getting any positive press at all.
- Forums
- ASX - By Stock
- PGH
- Ann: 2023 Half-Year Results Presentation
Ann: 2023 Half-Year Results Presentation, page-26
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGH (ASX) to my watchlist
|
|||||
Last
79.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $271.9M |
Open | High | Low | Value | Volume |
76.5¢ | 79.0¢ | 76.5¢ | $451 | 579 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 718 | 76.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.0¢ | 214 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.765 |
1 | 50000 | 0.760 |
1 | 1329 | 0.750 |
2 | 1900 | 0.730 |
1 | 7187 | 0.705 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 41967 | 3 |
0.840 | 2000 | 1 |
0.845 | 1714 | 2 |
0.850 | 2740 | 2 |
0.860 | 14205 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PGH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online